XERIS PHARMACEUTICALS INC Stock Split Ratio
XERIS PHARMACEUTICALS INC reported Stock Split Ratio of 178.11% for the 3-month period ending 2018-06-30, per its 10-K filed 2020-03-12.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-12
- XERIS PHARMACEUTICALS INC stockholders' equity note, stock split, conversion ratio for the quarter ending 2018-06-30 was 178.11%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month |
|---|---|
| 2018-06-30 | 178.11% 10-K · filed 2020-03-12 |